Drug development takes an average of 15 years, costs billions of dollars, and most therapies still fail before reaching patients.

In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss discuss one of the biggest problems in modern drug development: animal models that may not accurately predict what happens in humans.

They explore why only a small percentage of therapies that work in mice ultimately succeed in people, how that impacts timelines and costs, and why the industry may need to rethink how therapies are tested.

The conversation also looks at the broader implications for pharmaceutical pricing, innovation, and the future of medicine if more predictive testing systems can be developed.

Topics covered include:

• Why most therapies that work in mice fail in humans• The cost and timeline challenges in drug development• The future of more predictive testing systems

🎧 Listen on Spotify and Apple Podcasts📺 Subscribe for more conversations on science, medicine, and innovation.

Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/litt

Follow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/X: https://x.com/GoodMedicinePodTikTok: https://www.tiktok.com/@good.medicine.podcastLinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/